Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02136095
Other study ID # IFC_Feasibility_study
Secondary ID
Status Completed
Phase N/A
First received May 7, 2014
Last updated May 8, 2014
Start date September 2013
Est. completion date December 2013

Study information

Verified date May 2014
Source Hvidovre University Hospital
Contact n/a
Is FDA regulated No
Health authority Denmark: Danish Health and Medicines Authority
Study type Interventional

Clinical Trial Summary

Intraoperative fluorescent cholangiography (IFC) with concomitant fluorescent angiography is a recently developed method for non-invasive visualisation of the relevant anatomy during laparoscopic cholecystectomy. The objective of this study was to assess the time required by routine-use of IFC and to evaluate success-rate of the procedures.

Methods Thirty-five patients scheduled for laparoscopic cholecystectomy and operated by the same surgeon were consecutively enrolled. A standardized protocol with IFC including concomitant angiography was performed during laparoscopic cholecystectomy. Intra-operative time-registration and exposure of predefined anatomical structures were recorded.


Recruitment information / eligibility

Status Completed
Enrollment 35
Est. completion date December 2013
Est. primary completion date December 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 75 Years
Eligibility Inclusion criteria:

- Age > 18 years

- Scheduled for acute- or elective laparoscopic cholecystectomy

- Informed consent

Exclusion criteria:

- Known iodine-hypersensitivity

- Liver- or renal insufficiency

- Known thyrotoxicosis

- Pregnancy or lactation

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Intervention

Procedure:
Intraoperative fluorescent cholangiography (IFC)
A standardized protocol with IFC including concomitant angiography was performed during laparoscopic cholecystectomy.

Locations

Country Name City State
Denmark Hvidovre University Hospital Hvidovre

Sponsors (1)

Lead Sponsor Collaborator
Hvidovre University Hospital

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time expenditure of IFC with concomitant angiography. Intra-operative fluorescent-imaging-mode-time was registered by a study-nurse during the operations (performed between september and december 2013) Four months No
Secondary Success-rate of the IFC-procedures. The operating surgeon completed a structured questionnaire immediately after each operation regarding anatomical identification by IFC (visible cystic duct, -common bile duct, -common hepatic duct, -right and left hepatic ducts, -cystic artery, -aberrant bile ducts, and/or other abnormalities).
Successful IFC was defined as exposure of the junction between the cystic duct, common bile duct and common hepatic duct by IFC. Success-full fluorescent angiography was defined as adequate visualisation of the cystic artery within Calot´s triangle by the method.
Four months No
See also
  Status Clinical Trial Phase
Recruiting NCT02568852 - Comparison of Coagulation Factors During Laparoscopic Cholecystectomy N/A
Completed NCT01103570 - Cholecyst- Versus Cystic Duct Cholangiography During Laparoscopic Cholecystectomy Phase 4
Completed NCT02327923 - Intraoperative Lidocaine Infusion vs. Esmolol Infusion for Postoperative Analgesia in Laparoscopic Cholecystectomy Phase 4
Completed NCT02317510 - Combined Spinal Epidural Anesthesia and General Anesthesia for Laparoscopic Cholecystectomy N/A